 NEW YORK, March 19, 2021 PRNewswire -- Hoth Therapeutics, Inc. Nasdaq: HOTH, a patient-focused clinical-stage biopharmaceutical company, today announced an exclusive interview featuring Robb Knie, CEO, airing on The RedChip Money Report on the Bloomberg Television U.S. on Saturday, March 20th at 7 p.m. local time across the United States. 